Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus - PubMed (original) (raw)
doi: 10.1038/ng1383. Epub 2004 Jun 27.
Affiliations
- PMID: 15220917
- DOI: 10.1038/ng1383
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus
Young-Kwon Hong et al. Nat Genet. 2004 Jul.
Abstract
Kaposi sarcoma is considered a neoplasm of lymphatic endothelium infected with Kaposi sarcoma-associated herpesvirus. It is characterized by the expression of lymphatic lineage-specific genes by Kaposi sarcoma tumor cells. Here we show that infection of differentiated blood vascular endothelial cells with Kaposi sarcoma-associated herpesvirus leads to their lymphatic reprogramming; induction of approximately 70% of the main lymphatic lineage-specific genes, including PROX1, a master regulator of lymphatic development; and downregulation of blood vascular genes.
Similar articles
- Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Mäkinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. Wang HW, et al. Nat Genet. 2004 Jul;36(7):687-93. doi: 10.1038/ng1384. Epub 2004 Jun 27. Nat Genet. 2004. PMID: 15220918 - The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus.
Choi D, Park E, Kim KE, Jung E, Seong YJ, Zhao L, Madhavan S, Daghlian G, Lee HH, Daghlian PT, Daghlian S, Bui K, Koh CJ, Wong AK, Cho IT, Hong YK. Choi D, et al. Cancer Res. 2020 Aug 1;80(15):3130-3144. doi: 10.1158/0008-5472.CAN-19-3105. Epub 2020 Jun 9. Cancer Res. 2020. PMID: 32518204 Free PMC article. - Prox1, master regulator of the lymphatic vasculature phenotype.
Hong YK, Detmar M. Hong YK, et al. Cell Tissue Res. 2003 Oct;314(1):85-92. doi: 10.1007/s00441-003-0747-8. Epub 2003 Jul 22. Cell Tissue Res. 2003. PMID: 12883994 Review. - Spindle cells and their role in Kaposi's sarcoma.
Gessain A, Duprez R. Gessain A, et al. Int J Biochem Cell Biol. 2005 Dec;37(12):2457-65. doi: 10.1016/j.biocel.2005.01.018. Epub 2005 Aug 1. Int J Biochem Cell Biol. 2005. PMID: 16188485 Review. - Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.
Aguilar B, Choi I, Choi D, Chung HK, Lee S, Yoo J, Lee YS, Maeng YS, Lee HN, Park E, Kim KE, Kim NY, Baik JM, Jung JU, Koh CJ, Hong YK. Aguilar B, et al. Cancer Res. 2012 Nov 15;72(22):5833-42. doi: 10.1158/0008-5472.CAN-12-1229. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942256 Free PMC article.
Cited by
- Mapping herpesvirus-driven impacts on the cellular milieu and transcriptional profile of Kaposi sarcoma in patient-derived mouse models.
Li X, Ohler ZW, Day A, Bassel L, Grosskopf A, Afsari B, Tagawa T, Custer W, Mangusan R, Lurain K, Yarchoan R, Ziegelbauer J, Ramaswami R, Krug LT. Li X, et al. bioRxiv [Preprint]. 2024 Sep 28:2024.09.27.615429. doi: 10.1101/2024.09.27.615429. bioRxiv. 2024. PMID: 39386738 Free PMC article. Preprint. - Prognostic analysis of cutaneous Kaposi sarcoma based on a competing risk model.
Qian B, Qian Y, Xiao P, Guo L. Qian B, et al. Sci Rep. 2023 Oct 16;13(1):17572. doi: 10.1038/s41598-023-44800-5. Sci Rep. 2023. PMID: 37845261 Free PMC article. - A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R, Kasonkanji E, Gumulira J, Gondwe Y, Dewey M, Pan Y, Peng A, Pluta LJ, Kudowa E, Nyasosela R, Tomoka T, Tweya H, Heller T, Gugsa S, Phiri S, Moore DT, Damania B, Painschab M, Hosseinipour MC, Dittmer DP. Moorad R, et al. Int J Cancer. 2023 Dec 15;153(12):2082-2092. doi: 10.1002/ijc.34689. Epub 2023 Aug 21. Int J Cancer. 2023. PMID: 37602960 Free PMC article. - Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Damania B, Dittmer DP. Damania B, et al. J Med Virol. 2023 May;95(5):e28773. doi: 10.1002/jmv.28773. J Med Virol. 2023. PMID: 37212317 Free PMC article. Review. - Contribution of Epstein-Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses.
Dorothea M, Xie J, Yiu SPT, Chiang AKS. Dorothea M, et al. Cancers (Basel). 2023 Apr 2;15(7):2120. doi: 10.3390/cancers15072120. Cancers (Basel). 2023. PMID: 37046781 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources